Literature DB >> 27600311

Refined protocol for generating monoclonal antibodies from single human and murine B cells.

Irvin Y Ho1, Jeffrey J Bunker2, Steven A Erickson3, Karlynn E Neu4, Min Huang5, Mario Cortese6, Bali Pulendran7, Patrick C Wilson8.   

Abstract

Generating monoclonal antibodies from single B cells is a valuable tool for characterizing the specificity and functional properties of humoral responses. We and others developed protocols that have facilitated major advances in our understanding of B cell development, tolerance, and effector responses to HIV and influenza. Here, we demonstrate various refinements and dramatically reduce the time required to produce recombinant antibodies. Further, we present new methods for cloning and isolating antibodies from cells with lower immunoglobulin mRNA levels that may be resistant to traditional techniques. Together, these refinements significantly increase single-cell antibody expression efficiency and are easily integrated into established and novel pipelines.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody expression; Gibson assembly; Human antibodies; Monoclonal antibodies; Single-cell PCR

Mesh:

Substances:

Year:  2016        PMID: 27600311      PMCID: PMC5322767          DOI: 10.1016/j.jim.2016.09.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Predominant autoantibody production by early human B cell precursors.

Authors:  Hedda Wardemann; Sergey Yurasov; Anne Schaefer; James W Young; Eric Meffre; Michel C Nussenzweig
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

2.  Enzymatic assembly of DNA molecules up to several hundred kilobases.

Authors:  Daniel G Gibson; Lei Young; Ray-Yuan Chuang; J Craig Venter; Clyde A Hutchison; Hamilton O Smith
Journal:  Nat Methods       Date:  2009-04-12       Impact factor: 28.547

3.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

4.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

Authors:  Thomas Tiller; Eric Meffre; Sergey Yurasov; Makoto Tsuiji; Michel C Nussenzweig; Hedda Wardemann
Journal:  J Immunol Methods       Date:  2007-10-31       Impact factor: 2.303

5.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

6.  Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen.

Authors:  Kenneth Smith; Lori Garman; Jens Wrammert; Nai-Ying Zheng; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

7.  Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.

Authors:  Carole J Henry Dunand; Paul E Leon; Min Huang; Angela Choi; Veronika Chromikova; Irvin Y Ho; Gene S Tan; John Cruz; Ariana Hirsh; Nai-Ying Zheng; Caitlin E Mullarkey; Francis A Ennis; Masanori Terajima; John J Treanor; David J Topham; Kanta Subbarao; Peter Palese; Florian Krammer; Patrick C Wilson
Journal:  Cell Host Microbe       Date:  2016-06-08       Impact factor: 21.023

8.  Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies.

Authors:  Matthias F Muellenbeck; Beatrix Ueberheide; Borko Amulic; Alexandra Epp; David Fenyo; Christian E Busse; Meral Esen; Michael Theisen; Benjamin Mordmüller; Hedda Wardemann
Journal:  J Exp Med       Date:  2013-01-14       Impact factor: 14.307

  8 in total
  31 in total

1.  Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination.

Authors:  Karlynn E Neu; Jenna J Guthmiller; Min Huang; Jennifer La; Marcos C Vieira; Kangchon Kim; Nai-Ying Zheng; Mario Cortese; Micah E Tepora; Natalie J Hamel; Karla Thatcher Rojas; Carole Henry; Dustin Shaw; Charles L Dulberger; Bali Pulendran; Sarah Cobey; Aly A Khan; Patrick C Wilson
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

2.  Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.

Authors:  Wendy Béguelin; Matt Teater; Cem Meydan; Kenneth B Hoehn; Jude M Phillip; Alexey A Soshnev; Leandro Venturutti; Martín A Rivas; María T Calvo-Fernández; Johana Gutierrez; Jeannie M Camarillo; Katsuyoshi Takata; Karin Tarte; Neil L Kelleher; Christian Steidl; Christopher E Mason; Olivier Elemento; C David Allis; Steven H Kleinstein; Ari M Melnick
Journal:  Cancer Cell       Date:  2020-05-11       Impact factor: 31.743

3.  Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.

Authors:  Mark J Bailey; Felix Broecker; Alec W Freyn; Angela Choi; Julia A Brown; Nadia Fedorova; Viviana Simon; Jean K Lim; Matthew J Evans; Adolfo García-Sastre; Peter Palese; Gene S Tan
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

4.  Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.

Authors:  Ericka Kirkpatrick; Carole Henry; Meagan McMahon; Kaijun Jiang; Shirin Strohmeier; Harm van Bakel; Patrick C Wilson; Florian Krammer
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

5.  A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease.

Authors:  Anne H Rowley; Susan C Baker; David Arrollo; Leah J Gruen; Tetyana Bodnar; Nancy Innocentini; Matthew Hackbart; Yazmin E Cruz-Pulido; Kristine M Wylie; Kwang-Youn A Kim; Stanford T Shulman
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

6.  Early T follicular helper cell activity accelerates hepatitis C virus-specific B cell expansion.

Authors:  Eduardo Salinas; Maude Boisvert; Amit A Upadhyay; Nathalie Bédard; Sydney A Nelson; Julie Bruneau; Cynthia A Derdeyn; Joseph Marcotrigiano; Matthew J Evans; Steven E Bosinger; Naglaa H Shoukry; Arash Grakoui
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

7.  Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats.

Authors:  Carly Baehr; April Huseby Kelcher; Aaron Khaimraj; Dana E Reed; Sujata G Pandit; David AuCoin; Saadyah Averick; Marco Pravetoni
Journal:  J Pharmacol Exp Ther       Date:  2020-09-26       Impact factor: 4.030

8.  Natural polyreactive IgA antibodies coat the intestinal microbiota.

Authors:  Jeffrey J Bunker; Steven A Erickson; Theodore M Flynn; Carole Henry; Jason C Koval; Marlies Meisel; Bana Jabri; Dionysios A Antonopoulos; Patrick C Wilson; Albert Bendelac
Journal:  Science       Date:  2017-09-28       Impact factor: 47.728

9.  Affinity-Restricted Memory B Cells Dominate Recall Responses to Heterologous Flaviviruses.

Authors:  Rachel Wong; Julia A Belk; Jennifer Govero; Jennifer L Uhrlaub; Dakota Reinartz; Haiyan Zhao; John M Errico; Lucas D'Souza; Tyler J Ripperger; Janko Nikolich-Zugich; Mark J Shlomchik; Ansuman T Satpathy; Daved H Fremont; Michael S Diamond; Deepta Bhattacharya
Journal:  Immunity       Date:  2020-10-02       Impact factor: 31.745

10.  Human antibody response to Zika targets type-specific quaternary structure epitopes.

Authors:  Matthew H Collins; Huy A Tu; Ciara Gimblet-Ochieng; Guei-Jiun Alice Liou; Ramesh S Jadi; Stefan W Metz; Ashlie Thomas; Benjamin D McElvany; Edgar Davidson; Benjamin J Doranz; Yaoska Reyes; Natalie M Bowman; Sylvia Becker-Dreps; Filemón Bucardo; Helen M Lazear; Sean A Diehl; Aravinda M de Silva
Journal:  JCI Insight       Date:  2019-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.